Tag: drug research


CONDITIONED PLACE PREFERENCE (CPP)

CONDITIONED PLACE PREFERENCE (CPP) The Conditioned Place Preference (CPP) paradigm is a widely utilized behavioral methodology in translational neuroscience and psychology designed to objectively assess the motivational or affective properties of environmental stimuli, most commonly pharmacological agents or natural rewards. Fundamentally, CPP tests whether the experience with a specific stimulus will reinforce the environmental context, […]

Read More

DIHYDROMORPHINE

Introduction and Nomenclature Dihydromorphine, often abbreviated as DHM, stands as a critical compound within the vast spectrum of opioid pharmacology, occupying a unique space defined by its semi-synthetic origin and its profound utility in neuroscientific research. Chemically derived from the naturally occurring alkaloid morphine, DHM is classified as an opioid agonist, distinguished by the saturation […]

Read More

PRECLINICAL PSYCHOPHARMACOLOGY

The Foundation of Preclinical Psychopharmacology Preclinical psychopharmacology constitutes the indispensable, foundational phase of drug development that precedes the initiation of clinical trials involving human subjects or populations. It is fundamentally defined as the comprehensive scientific investigation and evaluation of novel pharmacological agents intended for the treatment of psychiatric or neurological disorders, conducted primarily through rigorous […]

Read More